Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Molecular & Cellular Oncology Année : 2020

Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics

Résumé

We recently identified a previously unappreciated ability of antimitotics to propagate apoptotic priming across cancer cell populations. The underlying paracrine cytotoxic signal, fueled by undead cells activating the cGAS/STING pathway, is required for in vivo antitumor response and it can be further exploited by delayed, but not synchronous, BCL-xL inhibition.

Dates et versions

inserm-03319352 , version 1 (12-08-2021)

Identifiants

Citer

Steven Lohard, Philippe Juin, Sophie C Barillé-Nion. Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics. Molecular & Cellular Oncology, 2020, 7 (3), pp.1735912. ⟨10.1080/23723556.2020.1735912⟩. ⟨inserm-03319352⟩
37 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More